Reporting Cases of Telogen Effluvium as a Sequelae of COVID-19 Infection
January 2022
in “
Journal of Drug Delivery and Therapeutics
”
Studysummary This study reported that all ten COVID-19 patients experienced early onset of Telogen effluvium within three months of infection, after recovering without hospitalization.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer